Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
4F32A0A785CBEA10144237F1B07DBDBE

Local dental anesthesia in both simple and complex dental procedures. Septocaine and epinephrine 1:100,000 is preferred during operative or surgical procedures when improved visualization of the surgical field is desirable. Fast onset (1 to 9 minutes) to avoid delay before effective analgesia is achieved. Predictable duration of anesthesia: up to 60 minutes for infiltration injections and 120 minutes for nerve blocks. No-methylparaben formulation to avoid allergic reactions on sensitive patients. 100% latex free components to help reduce allergic responses. Terminal sterilization of product/cartridges for safe use. Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage. Includes: (5) Blisters of (10) 1.7ml cartridges. Total of (50) cartridges. Septocaine® is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. Septocaine® and epinephrine 1:100,000 is preferred during operative or surgical procedures when improved visualization of the surgical field is desirable. Reactions to Septocaine® (pain and headache, for example, or convulsions or respiratory arrest following accidental intravascular injection) are characteristic of those associated with other amide-type local anesthetics. Septocaine® contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Accidental intravascular injection may be associated with convulsions, followed by central nervous system or cardiorespiratory depression and coma, progressing ultimately to respiratory arrest. Dental practitioners and/or clinicians who employ local anesthetic agents should be well versed in diagnosis and management of emergencies that may arise from their use. Resuscitative equipment, oxygen, and other resuscitative drugs should be available for immediate use. Septocaine®, along with other local anesthetics, is capable of producing methemoglobinemia. The clinical signs of methemoglobinemia are cyanosis of the nail beds and lips, fatigue and weakness. If methemoglobinemia does not respond to administration of oxygen, administration of methylene blue intravenously 1-2 mg/kg body weight over a 5 minute period is recommended. Please see the Package Insert for prescribing information.

Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
42AB65877D3DFFC8829FE340E49B3E36

Local dental anesthesia in both simple and complex dental procedures. For most routine dental procedures Septocaine 1:200,000 is preferred. Fast onset (1 to 9 minutes) to avoid delay before effective analgesia is achieved. Predictable duration of anesthesia: up to 60 minutes for infiltration injections and 120 minutes for nerve blocks. No-methylparaben formulation to avoid allergic reactions on sensitive patients. 100% latex free components to help reduce allergic responses. Terminal sterilization of product/cartridges for safe use. Includes: (5) Blisters of (10) 1.7ml cartridges. Total of (50) cartridges. Septocaine® is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. Septocaine® and epinephrine 1:100,000 is preferred during operative or surgical procedures when improved visualization of the surgical field is desirable. Reactions to Septocaine® (pain and headache, for example, or convulsions or respiratory arrest following accidental intravascular injection) are characteristic of those associated with other amide-type local anesthetics. Septocaine® contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Accidental intravascular injection may be associated with convulsions, followed by central nervous system or cardiorespiratory depression and coma, progressing ultimately to respiratory arrest. Dental practitioners and/or clinicians who employ local anesthetic agents should be well versed in diagnosis and management of emergencies that may arise from their use. Resuscitative equipment, oxygen, and other resuscitative drugs should be available for immediate use. Septocaine®, along with other local anesthetics, is capable of producing methemoglobinemia. The clinical signs of methemoglobinemia are cyanosis of the nail beds and lips, fatigue and weakness. If methemoglobinemia does not respond to administration of oxygen, administration of methylene blue intravenously 1-2 mg/kg body weight over a 5 minute period is recommended. Please see the Package Insert for prescribing information.

Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
Top Seller
435406D9BF3C09743C74E50EFC65F851
Top Seller
0F965C361C8E5F5872E9FC25C39EC882
Top Seller
512D620CC6A9A17E8FAB1F875DA569A1
Top Seller
DE001B97931051C5E87D4781DC925135
Top Seller
A8BE73598C6E6C27225A22A9843D65D4

Z3 3.4% Glutaraldehyde

3738-930

$34.19

Top Seller
29035F5FA1DF491C1489CEDB3FAF2995